Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.49 |
| ▸ | CA2 | P00918 | 3/20 | 0.45 |
| ▸ | CA1 | P00915 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.44 |
| ▸ | FPR2 | P25090 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | TYR | P14679 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | PYGL | P06737 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3434869 | 0.86 | LMNA (0.50) | GPR84CA2CA1ALDH1A1LMNA | |
| SCHEMBL11979054 | 0.80 | LMNA (0.53) | GPR84CA2CA1ALDH1A1LMNA | |
| SCHEMBL3360046 | 0.77 | GRN (0.51) | GPR84CA2CA1ALDH1A1LMNA | |
| SCHEMBL21185729 | 0.73 | ALDH1A1 (0.49) | GPR84CA2CA1ALDH1A1LMNA | |
| SCHEMBL15332731 | 0.72 | CA2 (0.47) | CA2CA1ALDH1A1FPR2MEN1 | |
| SCHEMBL29953517 | 0.72 | CA2 (0.47) | CA2CA1ALDH1A1FPR2MEN1 | |
| SCHEMBL21991765 | 0.71 | GPR84 (0.69) | GPR84CA1ALDH1A1LMNACYP1A2 | |
| SCHEMBL21185586 | 0.71 | KDM4E (0.47) | GPR84CA2CA1ALDH1A1LMNA | |
| SCHEMBL3433459 | 0.70 | GPR84 (0.41) | GPR84CA2CA1ALDH1A1LMNA | |
| SCHEMBL16543122 | 0.69 | CYP1A2 (0.61) | GPR84CA1ALDH1A1LMNACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8236952-B2 | Preparations containing amino acids and orotic acid | Northern Innovations Holding Corp. (CA) | 2012-08-07 | — | — | US | disclosed |
| US-8236952-B2 | Preparations containing amino acids and orotic acid | Northern Innovations Holding Corp. (CA) | 2012-08-07 | — | — | US | disclosed |
| US-8236952-B2 | Preparations containing amino acids and orotic acid | Northern Innovations Holding Corp. (CA) | 2012-08-07 | — | — | US | disclosed |
| EP-2231622-A1 | PREPARATIONS CONTAINING AMINO ACIDS AND OROTIC ACID | Northern Innovations and Formulations Corp. (CA) | 2010-09-29 | — | — | EP | disclosed |
| WO-2009076743-A1 | PREPARATIONS CONTAINING AMINO ACIDS AND OROTIC ACID | IOVATE T. & P. INC. (CA) | 2009-06-25 | — | — | WO | disclosed |
| WO-2009076743-A1 | PREPARATIONS CONTAINING AMINO ACIDS AND OROTIC ACID | IOVATE T. & P. INC. (CA) | 2009-06-25 | — | — | WO | disclosed |
| US-20090156812-A1 | PREPARATIONS CONTAINING AMINO ACIDS AND OROTIC ACID | IOVATE T. & P. INC. (CA) | 2009-06-18 | — | — | US | disclosed |
| US-20090156812-A1 | PREPARATIONS CONTAINING AMINO ACIDS AND OROTIC ACID | IOVATE T. & P. INC. (CA) | 2009-06-18 | — | — | US | disclosed |
| US-20090156812-A1 | PREPARATIONS CONTAINING AMINO ACIDS AND OROTIC ACID | IOVATE T. & P. INC. (CA) | 2009-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090156812-A1 | PREPARATIONS CONTAINING AMINO ACIDS AND OROTIC ACID | DDC, ODC1, OTC | GPR84 3114/4885CA2 566/4885CA1 95/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.